About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Peter MacCallum Cancer Centre
›
Cancer Immunology Program
›
Top Articles
Cancer Immunology Program
Peter MacCallum Cancer Centre
669
Articles
63.9K
Citations
7.3
avg. Impact Factor
129
h-index
Most Cited Articles of Cancer Immunology Program in 2009
Title
Journal
Year
Citations
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors
Nature Medicine
2009
1.3K
Enhancing the apoptotic and therapeutic effects of HDAC inhibitors
Cancer Letters
2009
184
Tumour suppression by p53: the importance of apoptosis and cellular senescence
Journal of Pathology
2009
141
The molecular basis for perforin oligomerization and transmembrane pore assembly
Immunity
2009
102
Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer
Proceedings of the National Academy of Sciences of the United States of America
2009
101
Endolysosomal proteases and their inhibitors in immunity
Nature Reviews Immunology
2009
99
Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer
Gene Therapy
2009
91
Type I natural killer T cells suppress tumors caused by p53 loss in mice
Blood
2009
87
Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapy
Journal of Immunology
2009
76
Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors
Blood
2009
72
Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth
PLoS ONE
2009
70
cAMP response element binding protein is required for mouse neural progenitor cell survival and expansion
Stem Cells
2009
65
Induction of natural killer T cell-dependent alloreactivity by administration of granulocyte colony-stimulating factor after bone marrow transplantation
Nature Medicine
2009
54
The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum
Journal of Immunotherapy
2009
47
The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity
Immunology and Cell Biology
2009
46
Perforin-mediated suppression of B-cell lymphoma
Proceedings of the National Academy of Sciences of the United States of America
2009
36
Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells
Tissue Antigens
2009
36
Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administration
Blood
2009
25
CD1d activation and blockade: a new antitumor strategy
Journal of Immunology
2009
24
CD1d-based combination therapy eradicates established tumors in mice
Journal of Immunology
2009
22
Chemokine-chemokine receptors in cancer immunotherapy
Immunotherapy
2009
21
Toll-Like Receptor Triggering and T-Cell Costimulation Induce Potent Antitumor Immunity in Mice
Clinical Cancer Research
2009
20
Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity
Journal of Immunology
2009
17
The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells
Haematologica
2009
16
Genetic modification of natural killer cells for adoptive cellular immunotherapy
Immunotherapy
2009
14
Schools/Departments
The list of schools/departments is not comprehensive since it is common to drop the department in the affiliation.
site/software ©
exaly
; All materials licenced under
CC by-SA
.